title: Should combination therapy with inhaled corticosteroids and long-acting beta2-agonists be prescribed as initial maintenance treatment for asthma?
authors.affiliation: Service de pneumologie, Université de Montréal, Montreal, Que. lemierec@crhsc.umontreal.ca
authors.forename: Catherine
authors.initials: C
authors.lastname: Lemière
authors.forename: Allan
authors.initials: A
authors.lastname: Becker
authors.forename: Louis-Philippe
authors.initials: LP
authors.lastname: Boulet
authors.forename: Dennis
authors.initials: D
authors.lastname: Bowie
authors.forename: André
authors.initials: A
authors.lastname: Cartier
authors.forename: Donald
authors.initials: D
authors.lastname: Cockroft
authors.forename: Robert
authors.initials: R
authors.lastname: Cowie
authors.forename: Pierre
authors.initials: P
authors.lastname: Ernst
authors.forename: Mark
authors.initials: M
authors.lastname: Fitzgerald
authors.forename: Malcolm
authors.initials: M
authors.lastname: Sears
authors.forename: Sheldon
authors.initials: S
authors.lastname: Spier
mesh_terms: D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000420:Albuterol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000730:Androstadienes / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D000068297:Fluticasone-Salmeterol Drug Combination; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans
chemical_list: D000318:Adrenergic beta-Agonists; D000730:Androstadienes; D004338:Drug Combinations; D000068297:Fluticasone-Salmeterol Drug Combination; D005938:Glucocorticoids; D000420:Albuterol